Claudio Calonder

883 total citations
18 papers, 654 citations indexed

About

Claudio Calonder is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Claudio Calonder has authored 18 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Claudio Calonder's work include Psoriasis: Treatment and Pathogenesis (4 papers), Asthma and respiratory diseases (4 papers) and Dermatology and Skin Diseases (3 papers). Claudio Calonder is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (4 papers), Asthma and respiratory diseases (4 papers) and Dermatology and Skin Diseases (3 papers). Claudio Calonder collaborates with scholars based in Switzerland, United States and China. Claudio Calonder's co-authors include Paul R. Van Tassel, Frank Kolbinger, Gerard Bruin, Philip Jarvis, Klaus L. Leenders, Yi Cheng, Manfred Bodenlenz, Xiaoyu Jiang, Christian Loesche and Thomas R. Pieber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Physical Chemistry B and Langmuir.

In The Last Decade

Claudio Calonder

17 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Calonder Switzerland 12 193 193 142 119 117 18 654
Sándor Sávay United States 11 392 2.0× 317 1.6× 37 0.3× 180 1.5× 56 0.5× 14 1.2k
Naoki Sakurai Japan 18 540 2.8× 184 1.0× 8 0.1× 46 0.4× 38 0.3× 91 1.1k
S. TSUCHIYA Japan 15 227 1.2× 101 0.5× 16 0.1× 92 0.8× 21 0.2× 48 753
David A. Dunn United States 20 307 1.6× 72 0.4× 11 0.1× 147 1.2× 36 0.3× 46 908
Yanqun Li China 11 145 0.8× 269 1.4× 12 0.1× 60 0.5× 79 0.7× 17 772
Lars Boeckmann Germany 16 365 1.9× 38 0.2× 54 0.4× 92 0.8× 128 1.1× 45 1.1k
Zoltán Rozsnyay Hungary 12 353 1.8× 238 1.2× 11 0.1× 95 0.8× 34 0.3× 19 775
Susanne Koling Germany 6 339 1.8× 105 0.5× 57 0.4× 89 0.7× 8 0.1× 8 692
Lars-Ivo Partecke Germany 16 204 1.1× 155 0.8× 62 0.4× 142 1.2× 11 0.1× 21 813
Hiroyuki Watabe Japan 17 277 1.4× 68 0.4× 14 0.1× 56 0.5× 7 0.1× 46 778

Countries citing papers authored by Claudio Calonder

Since Specialization
Citations

This map shows the geographic impact of Claudio Calonder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Calonder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Calonder more than expected).

Fields of papers citing papers by Claudio Calonder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Calonder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Calonder. The network helps show where Claudio Calonder may publish in the future.

Co-authorship network of co-authors of Claudio Calonder

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Calonder. A scholar is included among the top collaborators of Claudio Calonder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Calonder. Claudio Calonder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Millar, Neal L., Iain B. McInnes, Frank Kolbinger, et al.. (2025). Targeting the IL-17A pathway for therapy in early-stage tendinopathy. RMD Open. 11(1). e004729–e004729. 2 indexed citations
2.
3.
Kolbinger, Frank, Franco Di Padova, Atul Deodhar, et al.. (2021). Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety. Pharmacology & Therapeutics. 229. 107925–107925. 29 indexed citations
4.
Kaul, Martin, Philip Jarvis, Izabela Rozenberg, et al.. (2020). First‐in‐human study demonstrating the safety and clinical efficacy of novel anti‐IL‐17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology. 35(5). 1143–1151. 24 indexed citations
5.
Hey, Adam, et al.. (2019). “Simulect” as a model compound for assessing placental transfer of monoclonal antibodies in minipigs. Reproductive Toxicology. 91. 142–146. 3 indexed citations
6.
Bruin, Gerard, И. А. Королева, Julie Milojevic, et al.. (2019). Secukinumab Treatment Does Not Alter the Pharmacokinetics of the Cytochrome P450 3A4 Substrate Midazolam in Patients With Moderate to Severe Psoriasis. Clinical Pharmacology & Therapeutics. 106(6). 1380–1388. 11 indexed citations
7.
Kolbinger, Frank, Christian Loesche, Marie‐Anne Valentin, et al.. (2016). β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis. Journal of Allergy and Clinical Immunology. 139(3). 923–932.e8. 180 indexed citations
8.
Ahene, Ago, Claudio Calonder, S. Scott Davis, et al.. (2013). Automation Practices in Large Molecule Bioanalysis: Recommendations from Group L5 of the Global Bioanalytical Consortium. The AAPS Journal. 16(1). 164–171. 3 indexed citations
9.
Oostrum, Jan van, Claudio Calonder, Markus Ehrat, et al.. (2008). Tracing pathway activities with kinase inhibitors and reverse phase protein arrays. PROTEOMICS - CLINICAL APPLICATIONS. 3(4). 412–422. 41 indexed citations
10.
Calonder, Claudio, Howard W.T. Matthew, & Paul R. Van Tassel. (2005). Adsorbed layers of oriented fibronectin: A strategy to control cell–surface interactions. Journal of Biomedical Materials Research Part A. 75A(2). 316–323. 27 indexed citations
11.
Calonder, Claudio, et al.. (2003). Protein adsorption: Kinetics and history dependence. Journal of Colloid and Interface Science. 268(1). 1–11. 84 indexed citations
12.
Calonder, Claudio, et al.. (2001). History dependence of protein adsorption kinetics. Proceedings of the National Academy of Sciences. 98(19). 10664–10669. 106 indexed citations
13.
Calonder, Claudio & Paul R. Van Tassel. (2001). Kinetic Regimes of Protein Adsorption. Langmuir. 17(14). 4392–4395. 55 indexed citations
14.
Calonder, Claudio, J. Talbot, & Jeremy J. Ramsden. (2000). The Distribution of Electron Donor−Acceptor Potential on Protein Surfaces. The Journal of Physical Chemistry B. 105(3). 725–729. 9 indexed citations
15.
Bruehlmeier, Matthias, Klaus L. Leenders, Peter Vontobel, et al.. (2000). Increased cerebral iron uptake in Wilson's disease: a 52Fe-citrate PET study.. PubMed. 41(5). 781–7. 48 indexed citations
16.
Calonder, Claudio, et al.. (1999). Kinetic modeling of 52Fe/52mMn-citrate at the blood-brain barrier by positron emission tomography.. PubMed. 73(5). 2047–55. 5 indexed citations
17.
Maguire, R. P., Claudio Calonder, & Klaus L. Leenders. (1997). An Investigation of Multiple Time/Graphical Analysis Applied to Projection Data: Theory and Validation. Journal of Computer Assisted Tomography. 21(2). 327–331. 12 indexed citations
18.
Iorio, Ernesto E. Di, Wayne Yu, Claudio Calonder, et al.. (1993). Protein dynamics in minimyoglobin: is the central core of myoglobin the conformational domain?. Proceedings of the National Academy of Sciences. 90(5). 2025–2029. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sándor Sávay Breakdown of academic impact, for papers by Naoki Sakurai Breakdown of academic impact, for papers by S. TSUCHIYA Breakdown of academic impact, for papers by David A. Dunn Breakdown of academic impact, for papers by Yanqun Li Breakdown of academic impact, for papers by Lars Boeckmann Breakdown of academic impact, for papers by Zoltán Rozsnyay Breakdown of academic impact, for papers by Susanne Koling Breakdown of academic impact, for papers by Lars-Ivo Partecke Breakdown of academic impact, for papers by Hiroyuki Watabe
Rankless by CCL
2026